SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-016874
Filing Date
2023-12-26
Accepted
2023-12-26 18:00:23
Documents
1
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-63914.html 4  
1 PRIMARY DOCUMENT marketforms-63914.xml 4 3913
  Complete submission text file 0001214659-23-016874.txt   5446
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Issuer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address
Ungaro Ursula (Reporting) CIK: 0001865511 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40060 | Film No.: 231514284